StockIQStockIQ.tech

Emergent BioSolutions Inc. (EBS) Stock Analysis

--

Free AI-powered analysis and research for Emergent BioSolutions Inc. stock

Sector: Healthcare

Full EBS report

Emergent BioSolutions Inc. (EBS) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze EBS Now β†’

πŸ“° Latest Update

Emergent BioSolutions Inc (EBS) (Q3 2026) Earnings Call Highlights: Revenue Timing Weighs on ...

Emergent BioSolutions Inc (EBS) reported Q3 2026 revenue of $110 million, significantly down from $231 million in Q3 2025, primarily due to revenue timing and competitive pressures in the naloxone market. The company raised its FY2026 adjusted gross margin guidance to 45%-47% and expects approximately $40 million in annualized savings from restructuring efforts. Despite challenges, year-to-date revenue remains in line with expectations at $500 million, with adjusted EBITDA at negative $5 million for the quarter.

Read full article β†’

History

People also watch

ISRG
Intuitive Surgical Inc.
--
REGN
Regeneron Pharmaceuticals Inc.
--
CVS
CVS Health Corporation
--
GH
Guardant Health, Inc.
--
DMAC
DiaMedica Therapeutics Inc.
--